Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 28, No. 3, 2009
Issue release date: October 2009
Section title: Review Article
Free Access
Dement Geriatr Cogn Disord 2009;28:187–195

The Role of Genetics in Delirium in the Elderly Patient

van Munster B.C.a, b · de Rooij S.E.b · Korevaar J.C.a
aDepartment of Clinical Epidemiology, Biostatistics and Bioinformatics, and bDepartment of Internal Medicine, Academic Medical Centre, Amsterdam, The Netherlands
email Corresponding Author

B.C. van Munster

Department of Clinical Epidemiology, Biostatistics and Bioinformatics

Room J1B-207-1, Academic Medical Centre, University of Amsterdam, PO Box 22660

NL–1100 DD Amsterdam (The Netherlands)

Tel. +31 20 566 6945, Fax +31 20 691 2683, E-Mail b.c.vanmunster@amc.uva.nl

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Delirium is an important neuropsychiatric syndrome in the elderly that is associated with an increase in mortality, impaired physical and cognitive recovery, and increased healthcare costs. Two important gaps in daily practice with delirium are the pathophysiological obscurity and the low recognition rates. Genetics offers the possibility to contribute knowledge to both of these gaps with its unique and diverse techniques. However, genetic studies in delirium have been scarce until recently, due to the nature of the diagnosis, the etiology of the syndrome, and the pitfalls inherent in the design of genetic studies. This review describes the barriers of this field of research and the implications for our current knowledge of delirium.

© 2009 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Review Article

Accepted: May 29, 2009
Published online: August 28, 2009
Issue release date: October 2009

Number of Print Pages: 9
Number of Figures: 1
Number of Tables: 2

ISSN: 1420-8008 (Print)
eISSN: 1421-9824 (Online)

For additional information: http://www.karger.com/DEM

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.